BMS "fundamentally disagree" with ICER's conclusions on elotuzumab Media release 04 June 2016 Pages: 2 - 2
Utility of cancer value frameworks: no "one-size-fits-all" solution Comment 04 June 2016 Pages: 7 - 7
Economic burden of shingles in adults decreasing in Canada Clinical study 04 June 2016 Pages: 12 - 12
Edoxaban dominates rivaroxaban for stroke prevention in NVAF Clinical study 04 June 2016 Pages: 13 - 13
Frequent disease monitoring in MBC − no benefit at high cost Clinical study 04 June 2016 Pages: 14 - 14
Hypertension treatment cost effective in more black patients Clinical study 04 June 2016 Pages: 16 - 16
Mental disorders account for highest medical spending in US Clinical study 04 June 2016 Pages: 18 - 18
No out-of-pocket costs better for children's primary care in the US Clinical study 04 June 2016 Pages: 19 - 19
Pay-for-performance programme has little effect on mortality Clinical study 04 June 2016 Pages: 21 - 21
Prevention of avoidable events reduces costs in cancer survivors Clinical study 04 June 2016 Pages: 24 - 24
PROMISE: similar costs for CTA and functional testing for CAD Clinical study 04 June 2016 Pages: 26 - 26
RA decisions in Europe based on efficacy and costs, not ICERs Clinical study 04 June 2016 Pages: 28 - 28
Survival differs in Herceptin Program versus trastuzumab trials Clinical study 04 June 2016 Pages: 30 - 30
Telerehabilitation cost effective after total knee replacement Clinical study 04 June 2016 Pages: 31 - 31
Utilisation of telemedicine low in rural Medicare beneficiaries Clinical study 04 June 2016 Pages: 33 - 33
Varicella vaccination cost effective, may delay asthma onset Clinical study 04 June 2016 Pages: 34 - 34